A Pharmacoepidemiological Study on the Association Between Bicalutamide Treated Prostate Cancer and Risk of Coronary Heart Disease (CHD) and Heart Failure (HF) in the General Practice Research Database (GPRD)
N/A
50 Years
84 Years
50 Years
84 Years
Not Enrolling
Male
Prostate Cancer
Male
Prostate Cancer
Trial Information
A Pharmacoepidemiological Study on the Association Between Bicalutamide Treated Prostate Cancer and Risk of Coronary Heart Disease (CHD) and Heart Failure (HF) in the General Practice Research Database (GPRD)
Inclusion Criteria:
- At least two years enrollment with the general practitioner
Exclusion Criteria:
- Patients with cancer before start date of the study
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Retrospective
Outcome Measure:
Coronary heart disease including acute myocardial infarction and death from CHD
Outcome Time Frame:
From study start 1 Jan 1999 through 31December 2006
Principal Investigator
LA García Rodríguez, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
CEIFE (Centro Español de Investigación Farmacoepidemiológica -Spanish Centre for Pharmacoepidemiologic Research) Almirante
Authority:
United Kingdom: Medicines and Healthcare Products Regulatory Agency
Study ID:
D6874C00008
NCT ID:
NCT00688532
Start Date:
December 2007
Completion Date:
June 2009
Related Keywords:
- Prostate Cancer
- Prostate cancer
- pharmacoepidemiology study
- Coronary Artery Disease
- Myocardial Ischemia
- Coronary Disease
- Heart Diseases
- Heart Failure
- Prostatic Neoplasms
Name | Location |
|---|
